Mirae Asset Global ETFs Holdings
LXRX icon

Mirae Asset Global ETFs Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-68,683
Closed -$31.6K – 3143
2025
Q1 		$31.6K Buy
68,683
+2,901
+4% +$1.83K ﹤0.01% 2922
2024
Q4 		$48.6K Buy
65,782
+2,824
+4% +$3.4K ﹤0.01% 2910
2024
Q3 		$98.8K Buy
62,958
+15,775
+33% +$28.1K ﹤0.01% 2714
2024
Q2 		$79.3K Buy
+47,183
New +$84.6K ﹤0.01% 2657

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LXRX Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2025, closing a stake of 68,683 shares — an estimated $31.6K sold.

Mirae Asset Global ETFs Holdings first reported a position in LXRX in Q2 2024 and held it in 4 quarters. The position peaked at $98.8K in Q3 2024. 123 funds tracked by Wall St. Rank hold LXRX as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Lexicon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 68,683 Lexicon Pharmaceuticals shares in Q2 2025, an estimated $31.6K.
  • Mirae Asset Global ETFs Holdings first reported a position in Lexicon Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Lexicon Pharmaceuticals position peaked at $98.8K in Q3 2024.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.